MUCINEX
Live / Applied — Second extension granted (statement of use) (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 15 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98499792
- Mark type
- Design + words
- Filed
- 15 Apr 2024
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Mark Lerner, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds
Owner
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
Prosecution history
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 2 GRANTED
- 10 Dec 2025 — SOU EXTENSION 2 FILED
- 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 09 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Oct 2024 — ASSIGNED TO EXAMINER